OregonTherapeutics
Developing cancer targeted therapy
- B2B
About OregonTherapeutics
Developing disruptive targeted therapy XCE853 for oncology, focusing on inhibiting protein disulfide isomerase Priority indication: advanced pancreatic cancer
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1–10 employees
- Headquarters
- paris, île de france, France
- Founded
- 2014
- Website
- oregon-therapeutics.com
OregonTherapeutics at a glance
OregonTherapeutics is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in paris, île de france, France.
OregonTherapeutics was founded in 2014.
OregonTherapeutics has 1–10 employees.
Selling to companies like OregonTherapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies